Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve unaudited Financial Results ....
MEDICAMEQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medicamen Biotech Limited has informed BSE that its Board of Directors will meet on Friday, November 14, 2025, at its registered office in New Delhi. The main agenda is to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025 (Q2 FY26 and H1 FY26). The company has also reminded stakeholders that the trading window for designated persons will remain closed till November 16, 2025, in line with insider trading norms. No financial figures or business updates are disclosed in this filing, as it is a standard advance intimation under SEBI Listing Regulations.
This is a routine pre-results intimation with no financial impact disclosed. Investors should watch for the actual Q2/H1 FY26 results announcement on or after November 14, 2025, which could move the stock depending on the numbers reported.